The Patent Finder

Pieris Pharmaceuticals GmbH

26 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as Pieris AG (to 2016)

5
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Mar 3, 2027
  • 2 fees due Apr 3 to 6, 2027 · next Apr 3
  • 1 fee due May 28, 2027
    The maintenance fee for Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target (US 11,827,681) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 4 fees due Jun 10 to 29, 2027 · next Jun 10
  • 2 fees due Jul 7, 2027
  • 1 fee due Aug 16, 2027
    The maintenance fee for Muteins of Human Lipocalin 2 with Affinity for GLYPICAN-3 (GPC-3) (US 9,260,492) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for Anti-Cancer Fusion Polypeptide Capable of Binding Both CD137 and GLYPICAN-3 (GPC3) (US 11,919,931) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target (US 10,618,941) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 21, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,892,827Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (CTLA-4)
In force
 · High confidence
In forceHigh confidence
US 9,221,887Muteins of Tear Lipocalin and Methods for Obtaining the Same
In force
 · Medium confidence
In forceMedium confidence
US 8,313,924Muteins of Tear Lipocalin and Methods for Obtaining the Same
In force
 · High confidence
In forceHigh confidence
US 9,549,968Muteins of Human Lipocalin 2 (LCNC,HNGAL) with Affinity for a Given Target
In force
 · High confidence
In forceHigh confidence
US 10,618,941Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target
In force
 · High confidence
In forceHigh confidence
US 8,986,951Tear Lipocalin in Muteins Binding IL-4 R Alpha
In force
 · High confidence
In forceHigh confidence
US 10,232,014Tear Lipocalin Muteins Binding IL-4 R Alpha
In force
 · Low confidence
In forceLow confidence
US 11,827,681Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target
In force
 · High confidence
In forceHigh confidence
US 8,987,415Recombinant Bacterial Lipocalin BLC and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,260,492Muteins of Human Lipocalin 2 with Affinity for GLYPICAN-3 (GPC-3)
In force
 · High confidence
In forceHigh confidence
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
Also on record, not counted in the 26: 30 lapsed for an unpaid fee · 10 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited